BNP Paribas Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.56M Buy
509,642
+136,250
+36% +$1.7M 0.01% 836
2025
Q4
$4.83M Buy
373,392
+372,239
+32,284% +$4.78M 0.01% 854
2025
Q3
$15K Buy
1,153
+103
+10% +$1.38K ﹤0.01% 1501
2025
Q2
$19K Buy
+1,050
New +$18.3K ﹤0.01% 1516
2023
Q3
Sell
-11,090
Closed -$460K 856
2023
Q2
$460K Sell
11,090
-96,306
-90% -$5.98M ﹤0.01% 782
2023
Q1
$6.46M Sell
107,396
-3,246
-3% -$259K 0.02% 486
2022
Q4
$8.12M Sell
110,642
-4,386
-4% -$330K 0.03% 452
2022
Q3
$8.74M Sell
115,028
-1,536
-1% -$120K 0.03% 433
2022
Q2
$8.1M Buy
116,564
+113,866
+4,220% +$8.58M 0.03% 439
2022
Q1
$224K Buy
+2,698
New +$199K ﹤0.01% 851

Other funds holding NVCR